Tamoxifen and Breast Cancer Hearing Before the Committee on Appropriations, U.S. Senate

Hearing on the progress which has been made on Tamoxifen, specifically, the news about Raloxifene, a single pill a day having very dramatic results for women who are at high risk for breast cancer. Witnesses: Sen. Arlen Specter & Lauch Faircloth; Harold Varmus, Dir., Nat. Inst. of Health; Norman Wolmark, chairman, Nat. Surgical Adjuvant Breast & Bowel Project (NSABP) breast cancer prevention trial; Richard Klausner, Dir., National Cancer Institute; Helene Wilson, participant, NSABP breast cancer prevention trial; Cynthia Pearson, executive director, Nat. Women's Health Network; & Bernard Fisher, chairman & principal investigator, NSABP.Specter, Arlen is the author of 'Tamoxifen and Breast Cancer Hearing Before the Committee on Appropriations, U.S. Senate' with ISBN 9780756702618 and ISBN 0756702615.